Starpharma is a world leader in the development of dendrimer nanotechnology-based products for pharmaceutical and life sciences. It is based in Melbourne, Australia SPL is principally composed of two operating companies, Starpharma Pty Ltd in Melbourne, Australia and Dendritic Nanotechnologies, Inc in Michigan, USA. Products based on SPL’s dendrimer technology are already on the market in the form of diagnostic elements and laboratory reagents.

Acquired Companies: Dendritic Nanotechnologies Inc.